Advertisement

Topics

Asterias Biotherapeutics, Inc. Company Profile

22:21 EDT 19th September 2018 | BioPortfolio

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the stem cell assets of Geron Corporation, which was completed on October 1, 2013. That acquisition includes Geron’s entire cell therapy intellectual property portfolio, existing contracts and license agreements related to their stem cell programs, INDs for OPC1 and VAC1 cell therapies, master cell banks of hESCs and therapeutic cells manufactured under cGMP, research cell banks, customized reagents and equipment, and banks of cGMP-manufactured OPC1 drug product used in Geron’s Phase 1 trial in spinal cord injury, the world’s first human clinical trial of hESC-derived cells.


News Articles [246 Associated News Articles listed on BioPortfolio]

Asterias Biotherapeutics Announces New Exclusive License Agreement with The Regents of the University of California

Asterias Biotherapeutics (NYSE:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies...

Asterias gains patent rights for method to improve stroke recovery

Asterias Biotherapeutics has obtained exclusive rights to a University of California-owned patent family for a process relate -More- 

Cancer Research UK and Asterias Biotech initiate immunotherapy trial

Cancer Research UK has initiated a Phase I clinical trial in alliance with US-based Asterias Biotherapeutics to evaluate immunotherapy vaccine...Read More... The post Cancer Research UK and Asterias B...

CR UK tests Asterias’ novel lung cancer immunotherapy jab

Cancer Research UK has begun testing a novel immunotherapy vaccine for lung cancer in Phase I trials, under a collaboration agreement with Asterias Biotherapeutics.

Cancer Research, Asterias partner on lung cancer vaccine study

Cancer Research UK and Asterias Biotherapeutics agreed to work together to evaluate the AST-VAC2 vaccine in an early-stage st -More- 

Asterias enrols and doses first subject in Phase l trial of AST-VAC2

Asterias Biotherapeutics has enrolled and dosed the first subject in a Phase l clinical trial of AST-VAC2 for the treatment...Read More... The post Asterias enrols and doses first subject in Phase l t...

Cancer Research UK and Asterias Biotech initiate trial for immunotherapy vaccine

Cancer Research UK has initiated a Phase I clinical trial in alliance with US-based Asterias Biotherapeutics to evaluate immunotherapy vaccine...Read More... The post Cancer Research UK and Asterias B...

Asterias gains exclusive license to stroke IP from University of California

Asterias Biotherapeutics Inc. obtained from the Regents of the University of California an exclusive license covering rights in all fields of use to a patent family related to ischemic stroke.

Drugs and Medications [14 Associated Drugs and Medications listed on BioPortfolio]

Plasmanate [TALECRIS BIOTHERAPEUTICS, INC.]

Plasma Protein Fraction (Human) 5%, USPPlasmanate®

Gamastan s/d [TALECRIS BIOTHERAPEUTICS, INC.]

Immune Globulin (Human)GamaSTAN™ S/DSolvent/Detergent Treated

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 5%, USPPlasbumin ®-5

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 5%, USPPlasbumin ®-5

Plasbumin [TALECRIS BIOTHERAPEUTICS, INC.]

Albumin (Human) 20%, USPPlasbumin®-20

PubMed Articles [27 Associated PubMed Articles listed on BioPortfolio]

Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

Recent advances in synthetic biology and biological system engineering have allowed the design and construction of engineered live biotherapeutics targeting a range of human clinical applications. In ...

Cell Penetration Profiling Using the Chloroalkane Penetration Assay.

Biotherapeutics are a promising class of molecules in drug discovery, but they are often limited to extracellular targets due to their poor cell penetration. High-throughput cell penetration assays ar...

Discriminating Eaters: Sea Stars Asterias rubens L. Feed Preferably on Mytilus trossulus Gould in Mixed Stocks of Mytilus trossulus and Mytilus edulis L.

Sea stars Asterias rubens are important natural enemies of the blue mussel Mytilus in the North Atlantic. We asked whether these predators distinguish between the cryptic species M. edulis and M. tros...

Integrated BioTherapeutics.

Live bacterial biotherapeutics in the clinic.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)

Investigation of the efficacy and safety of triflusal in comparison with aspirin in patients with stable coronary artery disease (CAD) and in those with a history of an acute non-cardioemb...

Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)

The purpose of this study is to: - evaluate the safety profile of a single intravenous administration of AIGIV (containing either 3.5 mg/kg, 7.0 mg/kg or 14.0 mg/kg anti-PA IgG) a...

A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study

This is a Phase 2, randomized, double-blind, placebo-controlled crossover study which will enroll up to 36 subjects (anticipated) with genetically confirmed mitochondrial disease who have ...

The Effect of OASIS Ultra on Critical Sized Wound Healing

The aim of this study is to evaluate the speed and quality with which OASIS® Ultra (Healthpoint Biotherapeutics; Fort Worth, Texas) increases wound healing in the critical sized defect. ...

Personalized Immunotherapeutics for Antibiotic-resistant Infection

M. A. suffers from hypogammaglobulinemia that has been complicated by refractory Mycoplasma hominis septic arthritis. He has been receiving the antibiotic valnemulin under Emergency Invest...

Companies [101 Associated Companies listed on BioPortfolio]

BioTime, Inc. and Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics, Inc. is a leading biotechnology company in the emerging field of regenerative medicine. The company’s proprietary, industry leading platforms are ba...

Asterias Biotherapeutics, Inc.

Asterias Biotherapeutics is a subsidiary of BioTime, Inc., whose mission is to acquire and develop best in class cell therapy product candidates. Our first acquisition was the ste...

Axial Biotherapeutics

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics ...

Napro Biotherapeutics Incorporated

NaPro BioTherapeutics, Inc. is a natural product pharmaceutical company focused primarily on the development, manufacture and commercializa tion of paclitaxel, a naturally-occurring anti-cancer agent ...

Sephos Biotherapeutics

Sephos Biotherapeutics is a privately owned company focused on designing drugs for the treatment of cancer stem cells where the structure and biological activity of the drugs have...

More Information about "Asterias Biotherapeutics, Inc." on BioPortfolio

We have published hundreds of Asterias Biotherapeutics, Inc. news stories on BioPortfolio along with dozens of Asterias Biotherapeutics, Inc. Clinical Trials and PubMed Articles about Asterias Biotherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Asterias Biotherapeutics, Inc. Companies in our database. You can also find out about relevant Asterias Biotherapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record